Axolot Solutions (AXOLOT) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Feb, 2026Executive summary
Achieved strong revenue growth in 2025, driven by sales of AxoPur reactors and increased royalty and consulting income, reflecting successful commercial expansion and strategic partnership with Mellifiq.
Expanded market presence domestically and internationally, with significant activities and pilot projects in Latin America, especially Chile, Argentina, and Peru.
Completed delivery and installation of eight AxoPur reactors at Aspa Bruk, a key reference project expected to drive further large-scale customer projects.
Filed a patent application for a new selective sulfate purification technology, broadening the application range of AxoPur.
Financial highlights
Q4 2025 net sales: 1,946 tkr (Q4 2024: 256 tkr); full-year 2025 net sales: 10,591 tkr (2024: 256 tkr).
Q4 2025 operating result: -1,537 tkr (Q4 2024: -3,470 tkr); full-year 2025 operating result: -5,929 tkr (2024: -5,818 tkr).
Q4 2025 net result: -1,458 tkr (Q4 2024: -3,379 tkr); full-year 2025 net result: -5,937 tkr (2024: -18,008 tkr).
Cash flow from operations Q4 2025: -1,090 tkr (Q4 2024: -3,695 tkr); full-year: -4,332 tkr (2024: -6,123 tkr).
Cash and cash equivalents at year-end: 12,588 tkr (2024: 7,282 tkr).
Outlook and guidance
Entering 2026 with a strengthened business position, growing project pipeline, and increasing market recognition of AxoPur technology.
Expectation of further international expansion and new partnerships, with focus on Latin America and reference projects supporting future growth.
Latest events from Axolot Solutions
- Sales and operating results improved in Q3 2025, with accelerated international expansion.AXOLOT
Q3 202528 Oct 2025 - Order growth, international expansion, and regulatory tailwinds drive positive Q2 momentum.AXOLOT
Q2 202529 Jul 2025 - Q3 sales surged, but losses deepened as Axolot completed a transformative merger with Mellifiq.AXOLOT
Q3 202413 Jun 2025 - Sales up but losses widen; new funding secured for growth amid rising market demand.AXOLOT
Q2 202413 Jun 2025 - Q1 2025 saw Axolot's sales surge and key PFAS contracts secured via partner expansion.AXOLOT
Q1 20256 Jun 2025 - Strategic shift and major partnership drive Axolot's growth prospects despite 2024 losses.AXOLOT
Q4 20245 Jun 2025